Status and Update on Cardiac Resynchronization Therapy Trials

References

1. • Cazeau S.
   • Leclercq C.
   • Lavergne T.
   • et al.
   Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
   N Engl J Med. 2001; 344: 873-880
   View in Article

   • Google Scholar
2. • Tang A.S.
   • Wells G.A.
   • Talajic M.
   • et al.
   Resynchronization-defibrillation for ambulatory heart failure trial investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure.
   N Engl J Med. 2010; 363: 2385-2395
   View in Article

   • Google Scholar
3. • Linde C.
   • Leclercq C.
   • Rex S.
   • et al.
   Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.
   J Am Coll Cardiol. 2002; 40: 111-118
   View in Article

   • Google Scholar
4. • Auricchio A.
   • Stellbrink C.
   • Sack S.
   • et al.
   Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.
   J Am Coll Cardiol. 2002; 39: 2026-2033
   View in Article

   • Google Scholar
5. • Young J.B.
   • Abraham W.T.
   • Smith A.L.
   • et al.
   Multicenter InSync ICD randomized clinical evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
   JAMA. 2003; 289: 2685-2694
   View in Article

   • Google Scholar
6. • Moss A.J.
   • Hall W.J.
   • Cannom D.S.
   • et al.
   MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events.
   N Engl J Med. 2009; 361: 1329-1338
   View in Article

   • Google Scholar
7. • Abraham W.T.
   • Young J.B.
   • León A.R.
   • et al.
   Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
   Circulation. 2004; 110: 2864-2868
   View in Article

   • Google Scholar
8. • Bristow M.R.
   • Saxon L.A.
   • Boehmer J.
   • et al.
   Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
   N Engl J Med. 2004; 350: 2140-2150
   View in Article

   • Google Scholar
9. • Cleland J.G.
   • Daubert J.C.
   • Erdmann E.
   • et al.
   Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure.
   N Engl J Med. 2005; 352: 1539-1549
   View in Article

   • Google Scholar
10. • Glikson M.
    • Nielsen J.C.
    • Kronborg M.B.
    • et al.
    • ESC Scientific Document Group
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021; 42: 3427-3520
    View in Article

    • Google Scholar
11. • Kusumoto F.M.
    • Schoenfeld M.H.
    • Barrett C.
    • et al.
    2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Circulation. 2019; 140 ([Erratum appears in Circulation 2019;140(8):e506-e508]): e382-e482
    View in Article

    • Google Scholar
12. • Auricchio A.
    • Prinzen F.W.
    Enhancing response in the cardiac resynchronization therapy patient: the 3B perspective-bench, bits, and bedside.
    JACC Clin Electrophysiol. 2017; 3: 1203-1219
    View in Article

    • Google Scholar
13. • Mullens W.
    • Auricchio A.
    • Martens P.
    • et al.
    Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology.
    Eur J Heart Fail. 2020; 22: 2349-2369
    View in Article

    • Google Scholar
14. • Caputo M.L.
    • van Stipdonk A.
    • Illner A.
    • et al.
    The definition of left bundle branch block influences the response to cardiac resynchronization therapy.
    Int J Cardiol. 2018; 269: 165-169
    View in Article

    • Google Scholar
15. • Surawicz B.
    • Childers R.
    • Deal B.J.
    • et al.
    American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.
    J Am Coll Cardiol. 2009; 53: 976-981
    View in Article

    • Google Scholar
16. • Brignole M.
    • Pentimalli F.
    • Palmisano P.
    • et al.
    AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021; : ehab569https://doi.org/10.1093/eurheartj/ehab569
    View in Article

    • Google Scholar
17. • Merkely B.
    • Kosztin A.
    • Roka A.
    • et al.
    Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial.
    Europace. 2017; 19: 1549-1555
    View in Article

    • Google Scholar

18. Maffessanti F, Jadczyk T, Kurzelowski R, et al. The influence of scar on the spatio-temporal relationship between electrical and mechanical activation in heart failure patients. Europace. 2020 May 1;22(5):777-786. [Erratum in:Europace 2020;22(5):786].

    View in Article

    • Google Scholar
19. • Borgquist R.
    • Carlsson M.
    • Markstad H.
    • et al.
    Cardiac resynchronization therapy guided by echocardiography, MRI, and CT Imaging: a Randomized Controlled Study.
    JACC Clin Electrophysiol. 2020; 6: 1300-1309
    View in Article

    • Google Scholar
20. • Singh J.P.
    • Berger R.D.
    • Doshi R.N.
    • et al.
    • ENHANCE CRT Study Group
    Targeted left ventricular lead implantation strategy for non-left bundle branch block patients: the ENHANCE CRT Study.
    JACC Clin Electrophysiol. 2020; 6: 1171-1181
    View in Article

    • Google Scholar
21. • Niazi I.
    • Baker 2nd, J.
    • Corbisiero R.
    • et al.
    MPP investigators. safety and efficacy of multipoint pacing in cardiac resynchronization therapy: the MultiPoint Pacing Trial.
    JACC Clin Electrophysiol. 2017; 3: 1510-1518
    View in Article

    • Google Scholar
22. • Leclercq C.
    • Gadler F.
    • Kranig W.
    • et al.
    TRIP-HF (triple resynchronization in paced heart failure patients) Study Group. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    J Am Coll Cardiol. 2008; 51: 1455-1462
    View in Article

    • Google Scholar
23. • Pappone C.
    • Ćalović Ž.
    • Vicedomini G.
    • et al.
    Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: twelve-month follow-up study.
    Heart Rhythm. 2015; 12: 1250-1258
    View in Article

    • Google Scholar
24. • Osca J.
    • Alonso P.
    • Cano O.
    • et al.
    The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.
    Europace. 2016; 18: 560-567
    View in Article

    • Google Scholar
25. • Mehta V.S.
    • Elliott M.K.
    • Sidhu B.S.
    • et al.
    Multipoint pacing for cardiac resynchronisation therapy in patients with heart failure: a systematic review and meta-analysis.
    J Cardiovasc Electrophysiol. 2021; 32: 2577-2589
    View in Article

    • Google Scholar
26. • Leclercq C.
    • Burri H.
    • Curnis A.
    • et al.
    Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I.
    Eur Heart J. 2019; 40: 2979-2987
    View in Article

    • Google Scholar
27. • Almusaad A.
    • Sweidan R.
    • Alanazi H.
    • et al.
    Long-term reverse remodeling and clinical improvement by MultiPoint Pacing in a randomized, international, middle Eastern heart failure study.
    J Interv Card Electrophysiol. 2021; (Epub ahead of print)https://doi.org/10.1007/s10840-020-00928-2
    View in Article

    • Google Scholar
28. • Nunes Ferreira A.
    • Antonio P.S.
    • Aguiar-Ricardo I.
    • et al.
    P578Multipoint pacing in cardiac resynchronization therapy - how to improve remodeling criteria and its impact in quality of life.
    EP Europace. 2020; 22https://doi.org/10.1093/europace/euaa162.085
    View in Article

    • Google Scholar
29. • Leyva F.
    • Zegard A.
    • Okafor O.
    • et al.
    Survival after cardiac resynchronization therapy: results from 50 084 implantations.
    Europace. 2019; 21: 754-762
    View in Article

    • Google Scholar
30. • Marijon E.
    • Leclercq C.
    • Narayanan K.
    • et al.
    CeRtiTuDe Investigators. Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
    Eur Heart J. 2015; 36: 2767-2776
    View in Article

    • Google Scholar
31. • McDonagh T.A.
    • Metra M.
    • Adamo M.
    • et al.
    • ESC Scientific Document Group
    2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
    Eur Heart J. 2021; 42: 3599-3726
    View in Article

    • Google Scholar